GlassScriptPhysician profile
Caroline E Berrios
NPI 1679982771
$7,296.59
in general payments reported to CMS, 2019-2025
50 companies · $1,419 in 2025
The $1,419 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,703 · 2022: $1,267 · 2023: $1,387 · 2024: $1,522 · 2025: $1,419.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,327.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,327.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,753.17 | 2021-2025 | |
| Medtronic, INC. | $768.03 | 2022-2025 | Intellis Adaptivestim, Inceptiv, Accurian |
| Collegium Pharmaceutical, INC. | $696.28 | 2021-2025 | Xtampza, Belbuca |
| Boston Scientific Corporation | $437.02 | 2021-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Abbott Laboratories | $369.77 | 2021-2025 | Eterna, Proclaim |
| Pfizer INC. | $334.58 | 2021-2025 | |
| Averitas Pharma INC. | $245.75 | 2023-2025 | Qutenza |
| Nevro Corp. | $238.23 | 2021-2024 | Senza |
| Biohaven Pharmaceutical Holding Company LTD. | $195.58 | 2022 | |
| Merz Pharmaceuticals, LLC | $191.42 | 2021-2025 | Xeomin |
| Biohaven Pharmaceuticals, INC. | $186.29 | 2021 | |
| Vertos Medical, INC. | $174.61 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $133.64 | 2024-2025 | |
| Almatica Pharma LLC | $130.56 | 2021-2022 | |
| Lilly USA, LLC | $94.80 | 2021-2023 | Reyvow, Emgality |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Berrios listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.